Search Results - Luc W.M. Eurlings

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Impact of worsening renal function related to medication in heart failure

    Impact of worsening renal function related to medication in heart failure by Hans‐Peter Brunner‐La Rocca, Christian Knackstedt, Luc W.M. Eurlings, Vinzent Rolny, Friedemann Krause, Matthias Pfisterer, Daniel Tobler, Peter Rickenbacher, Micha T. Maeder

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure

    Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure by Khibar Salah, Wouter E.M. Kok, Luc W.M. Eurlings, Paulo Bettencourt, Joana Pimenta, Marco Metra, Valerio Verdiani, Jan G.P. Tijssen, Yigal M. Pinto

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction

    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction by Khibar Salah, Susan Stienen, Yigal M. Pinto, Luc W.M. Eurlings, Marco Metra, Antoni Bayés‐Genís, Valerio Verdiani, Jan G.P. Tijssen, Wouter E.M. Kok

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation

    Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation by Robby Nieuwlaat, Luc W.M. Eurlings, John G.F. Cleland, Stuart M. Cobbe, Panos Vardas, Alessandro Capucci, José López‐Sendón, Joan G. Meeder, Yigal M. Pinto, Harry J.G.M. Crijns

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

    Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load by Robert Dennert, Sebastiaan Velthuis, Simon Schalla, Luc W.M. Eurlings, Robert‐Jan van Suylen, Pieter van Paassen, Jan William Cohen Tervaert, Petra Wolffs, Valère J. Goossens, Catrien Bruggeman, Johannes Waltenberger, Harry J.G.M. Crijns, Stéphane Heymans

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

    Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis by Richard W. Troughton, Chris Frampton, Hans‐Peter Brunner‐La Rocca, Matthias Pfisterer, Luc W.M. Eurlings, Hans Erntell, Hans Persson, Cathal O’Connor, Deddo Moertl, Patric Karlström, Ulf Dahlström, Hannah K. Gaggin, James L. Januzzi, Rudolf Berger, Mark Richards, Yigal M. Pinto, M. Gary Nicholls

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening

    Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening by Lucas Van Aelst, Sandra Voss, Paolo Carai, Rick van Leeuwen, Davy Vanhoutte, Sandra Sanders‐van Wijk, Luc W.M. Eurlings, Melissa Swinnen, Fons K. Verheyen, Eric Verbeken, Holger Nef, Christian Troidl, Stuart A. Cook, Hans‐Peter Brunner‐La Rocca, Helge Möllmann, Anna‐Pia Papageorgiou, Stéphane Heymans

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials

    Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials by Hans‐Peter Brunner‐La Rocca, Luc W.M. Eurlings, Mark Richards, James L. Januzzi, Matthias Pfisterer, Ulf Dahlström, Yigal M. Pinto, Patric Karlström, Hans Erntell, Rudolf Berger, Hans Persson, Christopher M. O’Connor, Deddo Moertl, Hanna K. Gaggin, Christopher Frampton, M. Gary Nicholls, Richard W. Troughton

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets

    Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets by Luc W.M. Eurlings, Petra E.J. van Pol, Wouter E.M. Kok, Sandra van Wijk, Cara Lodewijks-van der Bolt, Aggie H.M.M. Balk, Dirk J. Lok, Harry J.G.M. Crijns, D.J.W. van Kraaij, Nicolaas de Jonge, Joan G. Meeder, Martin H. Prins, Yigal M. Pinto

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: